within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01B_Antimalarials.P01BF02_ArtesunateAndMefloquine;

model ArtesunateAndMefloquine
  extends Pharmacolibrary.Drugs.ATC.P.P01BF02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>P01BF02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Artesunate and mefloquine is a fixed-dose combination antimalarial therapy used for the treatment of uncomplicated Plasmodium falciparum malaria. Artesunate is a fast-acting artemisinin derivative, while mefloquine is a longer-acting antimalarial agent. This combination is approved and widely used in endemic regions as a standard therapy for malaria.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for artesunate and mefloquine in healthy adult subjects, mostly from Southeast Asia, following oral administration of the fixed-dose combination.</p><h4>References</h4><ol><li><p>Rattanapunya, S, et al., &amp; Na-Bangchang, K (2015). Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults. <i>Malaria journal</i> 14 400–None. DOI:<a href=&quot;https://doi.org/10.1186/s12936-015-0916-8&quot;>10.1186/s12936-015-0916-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26452725/&quot;>https://pubmed.ncbi.nlm.nih.gov/26452725</a></p></li><li><p>Morris, CA, et al., &amp; Fleckenstein, L (2011). Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. <i>Malaria journal</i> 10 263–None. DOI:<a href=&quot;https://doi.org/10.1186/1475-2875-10-263&quot;>10.1186/1475-2875-10-263</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21914160/&quot;>https://pubmed.ncbi.nlm.nih.gov/21914160</a></p></li><li><p>Valea, I, et al., &amp; Ward, SA (2014). Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso. <i>The Journal of antimicrobial chemotherapy</i> 69(9) 2499–2507. DOI:<a href=&quot;https://doi.org/10.1093/jac/dku154&quot;>10.1093/jac/dku154</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24891429/&quot;>https://pubmed.ncbi.nlm.nih.gov/24891429</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ArtesunateAndMefloquine;
